AVORO CAPITAL ADVISORS LLC 13D and 13G filings for CymaBay Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 09:09 am Purchase | 2023-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | AVORO CAPITAL ADVISORS LLC | 16,337,739 9.990% | 3,537,739 (+27.64%) | Filing |
| 2022-02-11 10:03 am Purchase | 2021-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | AVORO CAPITAL ADVISORS LLC | 12,800,000 14.700% | 2,500,000 (+24.27%) | Filing |
| 2020-09-01 12:25 pm Purchase | 2020-08-31 | 13G | CymaBay Therapeutics, Inc. CBAY | AVORO CAPITAL ADVISORS LLC | 10,300,000 14.950% | 4,800,000 (+87.27%) | Filing |
| 2020-02-14 10:21 am Purchase | 2019-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | AVORO CAPITAL ADVISORS LLC | 5,500,000 8.000% | 5,500,000 (New Position) | Filing |